A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis (NCT07321873)
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-88545223 For the Treatment of Participants With Active Psoriatic Arthritis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of PsA and improve joint and skin health.
Who can join: Review the eligibility criteria below.
Location: Unity Health-White County Medical Center — Searcy, Arkansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (73 Sites)
Showing the first 25 of 73 sites.
- Unity Health-White County Medical Center — Searcy, Arkansas
- Newport Huntington Medical Group — Huntington Beach, California
- Rheumatology Center of San Diego — San Diego, California
- American Research, LLC — Cutler Bay, Florida
- Innovation Medical Research Center — Palmetto Bay, Florida
- Integral Rheumatology And Immunology Specialists — Plantation, Florida
- Clinical Research of West Florida — Tampa, Florida
- Conquest Research — Winter Park, Florida
- Atlanta Research Center for Rheumatology — Marietta, Georgia
- Willow Rheumatology and Wellness PLLC — Willowbrook, Illinois
- Qualmedica Research — Evansville, Indiana
- Albuquerque Rehabilitation and Rheumatology — Albuquerque, New Mexico
- Joint and Muscle Research Institute — Charlotte, North Carolina
- Paramount Medical Research & Consulting — Middleburg Heights, Ohio
- Clinical Research Philadelphia — Philadelphia, Pennsylvania
- Arthritis and Rheumatology Research Institute — Frisco, Texas
- Peking University People's Hospital — Beijing,
- Peking University Third Hospital — Beijing,
- Beijing Tsinghua Changgung Hospital — Beijing,
- Xiangya Hospital Central South University — Changsha,
- Changzhou No 2 Peoples Hospital — Changzhou,
- West China Hospital Sichuan University — Chengdu,
- The First Affiliated Hospital of Chongqing Medical University — Chongqing,
- The Second Affiliated Hospital of Zhejiang University — Hangzhou,
- Ningbo medical center lihuili hospital — Ningbo,
📞 Contact the Study Coordinator
Phone: (844) 434-4210
Email: Participate-In-This-Study1@its.jnj.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Arthritis, Psoriatic
- A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice — Buenos Aires,
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Avondale, Arizona
- A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis — Jonesboro, Arkansas
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Avondale, Arizona
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Birmingham, Alabama
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Glendale, Arizona
Explore by condition: All Arthritis, Psoriatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.